MANZOLI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 10.576
AS - Asia 9.604
EU - Europa 8.249
AF - Africa 769
Continente sconosciuto - Info sul continente non disponibili 659
SA - Sud America 564
OC - Oceania 26
Totale 30.447
Nazione #
US - Stati Uniti d'America 10.325
IT - Italia 2.739
SG - Singapore 2.701
CN - Cina 2.359
VN - Vietnam 2.283
GB - Regno Unito 1.265
DE - Germania 987
SE - Svezia 915
HK - Hong Kong 609
FR - Francia 406
BR - Brasile 390
IN - India 370
RU - Federazione Russa 321
NL - Olanda 318
KR - Corea 309
JP - Giappone 222
BD - Bangladesh 215
UA - Ucraina 206
IE - Irlanda 205
TG - Togo 192
FI - Finlandia 189
SC - Seychelles 164
CA - Canada 144
CI - Costa d'Avorio 140
ZA - Sudafrica 139
AT - Austria 106
CH - Svizzera 98
BG - Bulgaria 87
EE - Estonia 87
HR - Croazia 86
AR - Argentina 81
NG - Nigeria 68
JO - Giordania 67
ID - Indonesia 62
PH - Filippine 61
BE - Belgio 59
TH - Thailandia 59
TR - Turchia 45
PL - Polonia 38
PK - Pakistan 37
ES - Italia 35
MX - Messico 34
IQ - Iraq 30
TW - Taiwan 28
EC - Ecuador 23
RO - Romania 22
UZ - Uzbekistan 22
IR - Iran 21
SA - Arabia Saudita 21
CO - Colombia 19
GR - Grecia 19
AU - Australia 18
JM - Giamaica 18
LT - Lituania 15
CR - Costa Rica 12
IL - Israele 12
TN - Tunisia 12
UY - Uruguay 12
EG - Egitto 11
MA - Marocco 11
PY - Paraguay 11
VE - Venezuela 11
LB - Libano 10
MY - Malesia 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
SV - El Salvador 8
CZ - Repubblica Ceca 7
KE - Kenya 7
PT - Portogallo 7
GT - Guatemala 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
BZ - Belize 5
ET - Etiopia 5
LV - Lettonia 5
OM - Oman 5
PE - Perù 5
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
MD - Moldavia 4
NP - Nepal 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CY - Cipro 3
DZ - Algeria 3
GH - Ghana 3
NI - Nicaragua 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
Totale 29.750
Città #
Singapore 1.907
Ashburn 1.109
Southend 1.011
Bologna 854
Chandler 792
Fairfield 712
San Jose 625
Hong Kong 568
Santa Clara 554
Ho Chi Minh City 534
Hefei 511
Hanoi 482
Houston 412
Ann Arbor 404
Woodbridge 318
Dallas 304
Beijing 294
Boardman 290
Wilmington 289
Council Bluffs 280
Princeton 265
Seattle 263
Cambridge 229
Dong Ket 229
Dublin 205
Seoul 202
Milan 194
Lomé 192
New York 179
Frankfurt am Main 156
Tokyo 152
Lauterbourg 149
Los Angeles 149
Abidjan 140
Helsinki 126
Jacksonville 114
Nanjing 114
Padova 114
Westminster 107
Buffalo 99
Berlin 90
Da Nang 87
Sofia 86
Vienna 79
Rome 76
Haiphong 71
Turin 70
Bern 69
Munich 69
San Diego 68
Amman 65
Jinan 65
Abeokuta 64
Chicago 58
Redondo Beach 58
Redwood City 55
Saint Petersburg 55
Brussels 53
Johannesburg 51
Florence 50
Guangzhou 48
São Paulo 48
London 46
Redmond 46
Changsha 44
Medford 43
Parma 43
Shenyang 43
Toronto 43
Bengaluru 42
Orem 41
Shanghai 41
Amsterdam 40
Montreal 39
Moscow 39
Rimini 39
Udine 38
Bremen 37
Phoenix 36
The Dalles 35
Jakarta 34
Turku 33
Nanchang 32
Lappeenranta 30
Verona 30
San Francisco 29
Castel Maggiore 28
Nuremberg 28
Des Moines 27
Falkenstein 27
Hebei 27
Modena 27
Bangkok 26
Tianjin 26
Falls Church 25
Biên Hòa 24
Brooklyn 24
Hải Dương 24
Warsaw 24
Can Tho 22
Totale 18.345
Nome #
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 437
AEducaAR, Anatomical Education in Augmented Reality: A Pilot Experience of an Innovative Educational Tool Combining AR Technology and 3D Printing 395
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 372
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 296
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 292
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 291
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes 286
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 280
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma 279
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 275
Three-dimensional virtual anatomy as a new approach for medical student’s learning 264
Body donor reperfusion and re-ventilation in medical training: an Italian study testing SimLife® 261
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 259
Inositide-Dependent Nuclear Signalling in Health and Disease 256
Anatomic Cartography of the Hypogastric Nerves and Surgical Insights for Autonomic Preservation during Radical Pelvic Procedures. 250
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 249
In vitro reparative dentin: a biochemical and morphological study. 245
A scientific (c)old case at “Luigi Cattaneo” Anatomical Wax Collection in Bologna: solving an intriguing puzzle? 243
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 238
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 234
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 233
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 231
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 229
Dissecting human anatomy learning process through anatomical education with augmented reality: AEducAR 2.0, an updated interdisciplinary study 228
Augmented Reality-Assisted Periosteum Pedicled Flap Harvesting for Head and Neck Reconstruction: An Anatomical and Clinical Viability Study of a Galeo-Pericranial Flap 228
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 227
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 225
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 223
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant 222
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 221
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 218
Nuclear inositide signaling and cell cycle 213
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 211
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 211
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 210
Nuclear Inositide Signaling via Phospholipase C 210
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 209
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 209
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 209
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 209
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 208
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 207
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 206
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 206
Anatomical Study of the Application of a Galeo-Pericranial Flap in Oral Cavity Defects Reconstruction 205
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 205
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 205
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 204
The anatomy of the pelvic plexus in female cadavers: implications for retroperitoneal nerve-sparing surgery 202
To the Heart of IFs Function: Do they Aggregate on Purpose? 201
Signaling Role of Pericytes in Vascular Health and Tissue Homeostasis 200
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 198
Nuclear inositides: facts and perspectives. 198
The whole body donation program at the university of Bologna: A report based on the experience of one of the oldest university in Western world 197
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 196
Advances in MDS/AML and inositide signalling 195
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 194
Augmented Reality in Higher Education an Exploratory Study on the Beliefs of Medical Students 193
Anatomical variations of the right renal and spermatic arteries: a case report 193
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 193
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 191
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 191
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 191
PLA-Based Mineral-Doped Scaffolds Seeded with Human Periapical Cyst-Derived MSCs: A Promising Tool for Regenerative Healing in Dentistry 190
Investigation of human cadavers: one year of anatomic variants and their clinical correlation 189
Inositide signaling in the nucleus: From physiology to pathology. 188
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 188
Regulation of nuclear phospholipase C activity 187
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 187
Unilateral absence of Casserio’s nerve and a communicating branch to the median nerve. An additional variant of brachial flexors motor innervation 187
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 186
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 186
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 181
Lamin B1 as a key modulator of the developing and aging brain 180
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies 179
The anatomical wax collection at the University of Bologna: bridging the gap between tradition and scientific innovation 179
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 178
Nuclear phospholipase C beta1 and cellular differentiation. 178
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 178
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes 176
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE 174
Hypo and retrotympanum: the importance of anatomical variants 174
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 173
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 173
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 171
Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature 170
The involvement of signaling pathways in the pathogenesis of osteoarthritis: An update 169
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells 169
Anatomical Measurements of the Malar Bone for Safe Zygomatic Implant Placement: A Study on Donated Bodies 168
Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes 166
The variants of the retro- and hypotympanum: an endoscopic anatomical study 165
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 164
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 164
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 163
The Circle of Willis: a review and a case report 163
PLC and PI3K/Akt/mTOR signalling in disease and cancer 163
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress 163
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy 162
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients 161
Totale 21.162
Categoria #
all - tutte 82.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.800 0 54 174 284 239 142 133 185 105 497 526 461
2022/20233.506 338 443 172 518 299 265 221 220 529 61 211 229
2023/20241.457 95 196 139 145 152 203 67 81 100 131 64 84
2024/20254.583 166 520 361 296 664 250 404 202 136 367 321 896
2025/202611.363 917 1.231 1.085 768 1.179 630 1.203 342 2.010 867 597 534
2026/2027709 334 375 0 0 0 0 0 0 0 0 0 0
Totale 30.447